Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|March 31, 2015
Design, synthesis and biological evaluation of a highly-potent and cancer cell selective folate-taxoid conjugateJoshua D Seitz, Jacob G Vineberg, Evan Herlihy, et al.The British Journal of Clinical Practice|December 1, 1996
Bone mineral density in premenopausal women with oestrogen deficiency and symptomatic coronary heart diseaseB Bruck, D Seitz, S Hanke, et al.Journal of Radiosurgery and SBRT|December 7, 2020
Failure mode and effects analysis (FMEA) to enhance the safety and efficiency of Gamma Knife radiosurgeryRonald E Warnick, Amy R Lusk, John J Thaman, et al.Journal of Medicinal Chemistry|June 6, 2014
Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapyJacob G Vineberg, Edison S Zuniga, Anushree Kamath, et al.Dalton Transactions (Cambridge, England : 2003)|May 26, 2010
Bis-phenanthroline derivatives as suitable scaffolds for effective G-quadruplex recognitionS Bianco, C Musetti, A Waldeck, et al.Journal of Fluorine Chemistry|February 28, 2015
Design, Synthesis and Application of Fluorine-Labeled Taxoids as 19F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery SystemsJoshua D Seitz, Jacob G Vineberg, Longfei Wei, et al.Community Mental Health Journal|July 31, 2025
Prevalence of Mental Health and Substance Use Disorders Among Adolescents Experiencing Homelessness: A Systematic ReviewDavid Borkenhagen, G Messier, T Masrani, et al.Radiology|August 31, 2000
MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantationT Naegele, W Grodd, R Viebahn, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 7, 1999
[MR proton spectroscopy to monitor the concentration changes in cerebral metabolites following a TIPS placement]T Nägele, U Seeger, P Pereira, et al.Journal of the National Cancer Institute|December 2, 1992
Antitumor activity and clinical pharmacology of sulofenur in ovarian cancerC W Taylor, D S Alberts, Y M Peng, et al.Pageof 6